Merck KGaA, Pfizer Receive Positive EMA Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma

By: via Benzinga
Merck KGaA (OTC: MGKAY) and Pfizer (NYSE: PFE) today announced that the European Medicines Agency (EMA)'s Committee ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.